StockData
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31

Nutex Health Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$191.25+5.15 (+2.77%)

Close on Oct 19, 2026

Market cap
$1.34B
P/E (TTM)
7.5
Dividend yield
–

Nutex Health Inc. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
51.3%
Operating margin
43.0%
Net margin
21.2%
Return on equity, FY2025
30.7%

Financial strength

Current ratio
5.00
Debt to equity
0.10
Debt to assets
4.1%
Cash to current liabilities
175.1%

Valuation

P/E ratio
7.5
Price to sales
1.59
Price to book
3.41
Dividend yield
–